Lumos Pharma | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Celldex Therapeutics USD 17.14M 11.22M 2025-03
Cipla INR 8B 1.22B 2025-03
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 18.23M 11.01M 2024-12
CSL 1.52B 133M 2024-12
Eli Lilly USD 3.09B 175.1M 2025-03
Grifols EUR 979.78M 334.84M 2024-12
Incyte USD 2.41B 720.83M 2025-03
Merck USD 8.63B 4.61B 2025-03
Pfizer USD 1.43B 387M 2025-03
Prothena USD 471.39M 47.87M 2024-12
Sarepta Therapeutics USD 240.87M 862.14M 2025-03



Lumos Pharma Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.